Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma

Cancer Letters

Volumn 358, Issue 2, 2015, Pages 136-143

  Liu, Wen Ting ^a   Jing, Ying Ying ^a   Yu, Guo Feng ^b   Han, Zhi Peng ^a   Yu, Dan Dan ^a   Fan, Qing Min ^a   Ye, Fei ^a   Li, Rong ^a   Gao, Lu ^a   Zhao, Qiu Dong ^a   Wu, Meng Chao ^a   Wei, Li Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatocellular carcinoma; Toll like receptor 4; Tumor invasion and migration; Tumor initiating cells

Indexed keywords

TOLL LIKE RECEPTOR 4; TUMOR MARKER; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER CELL LINE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LYMPH VESSEL METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; ADULT; ANIMAL; CELL MOTION; DISEASE MODEL; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; TUMOR CELL LINE; TUMOR VOLUME;

MUS MUSCULUS;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PROGNOSIS; TOLL-LIKE RECEPTOR 4; TUMOR BURDEN;

EID: 84921442082     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.12.019     Document Type: Article

References (39)

1. Farazi P.A., DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 2006, 6:674-687.
2. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379:1245-1255.
3. Wu C., Alman B.A. Side population cells in human cancers. Cancer Lett 2008, 268:1-9.
4. Lobo N.A., Shimono Y., Qian D., Clarke M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol 2007, 23:675-699.
5. Magee J.A., Piskounova E., Morrison S.J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012, 21:283-296.
6. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
7. Hamburger A.W., Salmon S.E. Primary bioassay of human tumor stem cells. Science 1977, 197:461-463.
8. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
9. Yang Z.F., Ho D.W., Ng M.N., Lau C.K., Yu W.C., Ngai P., et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-166.
10. Lee T.K., Castilho A., Cheung V.C., Tang K.H., Ma S., Ng I.O. CD24 (+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011, 9:50-63.
11. Yamashita T., Ji J., Budhu A., Forgues M., Yang W., Wang H.Y., et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-1024.
12. Haraguchi N., Ishii H., Mimori K., Tanaka F., Ohkuma M., Kim H.M., et al. CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest 2010, 120:3326-3339.
13. Yang W., Yan H.X., Chen L., Liu Q., He Y.Q., Yu L.X., et al. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 2008, 68:4287-4295.
14. Tang Y., Kitisin K., Jogunoor W., Li C., Deng C.X., Mueller S.C., et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2445-2450.
15. Chen R., Alvero A.B., Silasi D.A., Steffensen K.D., Mor G. Cancers take their Toll-the function and regulation of Toll-like receptors in cancer cells. Oncogene 2008, 27:225-233.
16. Rakoff-Nahoum S., Medzhitov R. Toll-like receptors and cancer. Nat. Rev. Cancer 2009, 9:57-63.
17. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
18. Pimentel-Nunes P., Soares J.B., Roncon-Albuquerque R., Dinis-Ribeiro M., Leite-Moreira A.F. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin. Ther. Targets 2010, 14:347-368.
19. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. Practice Guidelines Committee AAftSoLD.
20. Khan S.A., Davidson B.R., Goldin R., Pereira S.P., Rosenberg W.M., Taylor-Robinson S.D., et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002, 51:VI1-VI9.
21. Aoki K., Takayasu K., Kawano T., Muramatsu Y., Moriyama N., Wakao F., et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 1993, 18:1090-1095.
22. Wu F., Yang L.Y., Li Y.F., Ou D.P., Chen D.P., Fan C. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 2009, 50:1839-1850.
23. Yang M.H., Chen C.L., Chau G.Y., Chiou S.H., Su C.W., Chou T.Y., et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50:1464-1474.
24. Zhang X., Liu S., Hu T., Liu S., He Y., Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50:490-499.
25. Ding W., You H., Dang H., LeBlanc F., Galicia V., Lu S.C., et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 2010, 52:945-953.
26. Fu J., Chen Y., Cao J., Luo T., Qian Y.W., Yang W., et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1 pathways. Hepatology 2011, 53:181-192.
27. Hua D., Liu M.Y., Cheng Z.D., Qin X.J., Zhang H.M., Chen Y., et al. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol. Immunol 2009, 46:2876-2884.
28. Gonzalez-Reyes S., Marin L., Gonzalez L., Gonzalez L.O., del Casar J.M., Lamelas M.L., et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 2010, 10:665.
29. Cammarota R., Bertolini V., Pennesi G., Bucci E.O., Gottardi O., Garlanda C., et al. The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J. Transl. Med 2010, 8:112.
30. Velazquez R.F., Rodriguez M., Navascues C.A., Linares A., Perez R., Sotorrios N.G., et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003, 37:520-527.
31. Poon R.T., Fan S.T., Lo C.M., Liu C.L., Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann. Surg 2007, 245:51-58.
32. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
33. Sun Y.F., Xu Y., Yang X.R., Guo W., Zhang X., Qiu S.J., et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 2013, 57:1458-1468.
34. Hang D., Dong H.C., Ning T., Dong B., Hou D.L., Xu W.G. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Dis. Esophagus 2012, 25:638-644.
35. Omran O.M. The prognostic value of breast cancer resistance protein (BCRB/ABCG2) expression in breast carcinomas. J. Environ. Pathol. Toxicol. Oncol 2012, 31:367-376.
36. Xiang L., Su P., Xia S., Liu Z., Wang Y., Gao P., et al. ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma. Diagn. Pathol 2011, 6:90.
37. Lee S.H., Hong B., Sharabi A., Huang X.F., Chen S.Y. Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. Stem Cells 2009, 27:1604-1615.
38. Machida K., Tsukamoto H., Mkrtchyan H., Duan L., Dynnyk A., Liu H.M., et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic onco-genesis involving stem cell marker Nanog. Proc. Natl. Acad. Sci. USA 2009, 106:1548-1553.
39. Chen C.L., Tsukamoto H., Liu J.C., Kashiwabara C., Feldman D., Sher L., et al. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. J. Clin. Invest 2013, 123:2832-2849.